Clinical trials of untested drugs is creating "havoc": SC

Image
Press Trust of India New Delhi
Last Updated : Jan 29 2013 | 2:34 PM IST

The apex court said that the government has gone into "deep slumber" on the issue and has failed to put in place proper mechanisms to stop "rackets" of multinational companies, which are conducting illegal clinical trials.

A bench of justices R M Lodha and A R Dave said in its interim order that all clinical trials will be done under the supervision of the Health Secretary at the Centre.

"You have to protect health of citizens of the country. It is your obligation. Deaths must be arrested and illegal trials must be stayed," the bench said, asking the government to handle the "menace" on an urgent basis.

It pulled up the government after it was contended that various committees have been set up to look into the issue and that it will come back to the court after getting suggestions from them.

"You can get back to the court but what about those people who are losing their lives in such clinical trials. People who lost their lives can't get their lives back," the bench observed.

"It is very easy to form a committee or a commission. It is done just to divert people's attention on the issue. It is the best way to divert attention on important issues," the bench said.

The court said that the government is "shying away" from responding to its queries while noting that the affidavit filed by the Centre was not in consonance with its earlier order. (More)

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 04 2010 | 2:45 PM IST

Next Story